Both in Pharmaceuticals
Kura Oncology vs Immix Biopharma
Over the past year KURA returned −23.6% and IMMX returned +139.3%; their daily moves had a correlation of 0.32.
KURA −23.6% IMMX +139.3%Growth of $1, one year, split-adjusted
| Metric | KURA | IMMX |
|---|---|---|
| Price | $7.61 | $7.97 |
| Market cap | $677.0M | $660.7M |
| Today | −22.98% | +3.37% |
| 1 month | −27.7% | −17.3% |
| 6 months | −20.4% | −22.8% |
| Year to date | −26.8% | +52.4% |
| 1 year | −22.1% | +119.0% |
| Revenue growth (YoY) | +36.5% | — |
| Gross margin | 98.8% | — |
| Net margin | −327.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 8.8× | — |
| Net cash | $509.2M | $232.1M |
| Dividend yield | — | — |
| Volatility (60d) | 76.9% | 64.4% |
| Short % of float | 18.3% | 22.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).